Maass Alexander H, Buck Sandra, Nieuwland Wybe, Brügemann Johan, van Veldhuisen Dirk J, Van Gelder Isabelle C
Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
J Cardiovasc Electrophysiol. 2009 Jul;20(7):773-80. doi: 10.1111/j.1540-8167.2008.01422.x. Epub 2009 Feb 2.
Cardiac resynchronization therapy (CRT) is an established therapy for patients with severe heart failure and mechanical dyssynchrony. Response is only achieved in 60-70% of patients.
To study exercise-related factors predicting response to CRT.
We retrospectively examined consecutive patients in whom a CRT device was implanted. All underwent cardiopulmonary exercise testing prior to implantation and after 6 months. The occurrence of chronotropic incompetence and heart rates exceeding the upper rate of the device, thereby compromising biventricular stimulation, was studied. Response was defined as a decrease in LVESV of 10% or more after 6 months.
We included 144 patients. After 6 months 86 (60%) patients were responders. Peak VO2 significantly increased in responders. Chronotropic incompetence was more frequently seen in nonresponders (21 [36%] vs 9 [10%], P = 0.03), mostly in patients in SR. At moderate exercise, defined as 25% of the maximal exercise tolerance, that is, comparable to daily life exercise, nonresponders more frequently went above the upper rate of the device (13 [22%] vs 2 [3%], P < 0.0001), most of whom were patients in permanent AF. Multivariate analysis revealed heart rates not exceeding the upper rate of the device during moderate exercise (OR 15.8 [3.3-76.5], P = 0.001) and nonischemic cardiomyopathy (OR 2.4 [1.0-5.7], P = 0.04) as predictive for response.
Heart rate exceeding the upper rate during moderate exercise is an independent predictor for nonresponse to CRT in patients with AF, whereas chronotropic incompetence is a predictor for patients in SR.
心脏再同步治疗(CRT)是用于重度心力衰竭和机械性不同步患者的既定疗法。仅60 - 70%的患者能取得疗效。
研究预测CRT疗效的运动相关因素。
我们回顾性分析了连续植入CRT装置的患者。所有患者在植入前及6个月后均接受了心肺运动试验。研究了变时性功能不全的发生情况以及心率超过装置上限从而影响双心室起搏的情况。疗效定义为6个月后左室舒张末期容积(LVESV)降低10%或更多。
我们纳入了144例患者。6个月后,86例(60%)患者有疗效。有疗效的患者峰值摄氧量显著增加。变时性功能不全在无疗效的患者中更常见(21例[36%]对9例[10%],P = 0.03),大多见于窦性心律(SR)患者。在定义为最大运动耐量25%的中等强度运动时,即相当于日常生活运动时,无疗效的患者更频繁地超过装置上限(13例[22%]对2例[3%],P < 0.0001),其中大多数是永久性房颤(AF)患者。多因素分析显示,中等强度运动时心率不超过装置上限(比值比[OR]15.8[3.3 - 76.5],P = 0.001)和非缺血性心肌病(OR 2.4[1.0 - 5.7],P = 0.04)可预测疗效。
中等强度运动时心率超过上限是房颤患者CRT无疗效的独立预测因素,而变时性功能不全是窦性心律患者的预测因素。